Optimal Duration of Chemotherapy in Advanced Non-Small Cell Lung Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-007-0020-6.pdf
Reference30 articles.
1. Cullen MH, Billingham LJ, Woodroffe CM, et al (1999) Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life. J Clin Oncol 17:3188–3194
2. Anonymous: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials—Non-small Cell Lung Cancer Collaborative Group. BMJ 1995, 311:899–909.
3. Wozniak AJ, Crowley JJ, Balcerzak SP, et al (2001) Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study. J Clin Oncol 16:2459–2465.
4. Sandler AB, Nemunaitis J, Denham C, et al (2000) Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18:122–130
5. D’Addario G, Pintilie M, Leighl N, Feld R, Cerny T, Shepherd FA (2005) Platinum –based versus non-platinum based chemotherapy in advanced non-small cell lung cancer: A meta-analysis of the published literature. J Clin Oncol 23:2926–2936
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biodegradable and Inherently Fluorescent pH-Responsive Nanoparticles for Cancer Drug Delivery;Pharmaceutical Research;2022-06-28
2. Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer;Translational Oncology;2019-04
3. A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302;Oncology;2019
4. Platinum drugs, copper transporters and copper chelators;Coordination Chemistry Reviews;2018-11
5. Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapy;Pharmaceutical Statistics;2015-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3